One of the first moves Elon Musk made when he took over X, formerly Twitter, was to slap a $42,000-per-month price tag on the enterprise Twitter API, while neutering the capabilities of the API's ...

To put that theory into practice, I teamed up with my friend Jared Bauman, built an AI-powered poem generator, and released ...

OpenAI released ChatGPT Images 2.0, a new image generator, on Thursday. The company teased the model by showing a fake screenshot. ChatGPT Images 2.0 can also generate images based on prompts written ...

In Matilda Goad’s Victorian terrace house, the kitchen is the first room you see. She designed it to make a good impression. Matilda Goad’s kitchen is customized to her every whim.Credit... Supported ...

The start-up said it would discontinue Sora just three months after signing a multiyear deal to bring Disney characters to the service. By Cade Metz Reporting from San Francisco OpenAI is shutting ...

Adobe has introduced Custom Models in public beta for Firefly, giving you a way to generate images in your own visual style instead of relying on generic AI outputs. By uploading your own images, you ...

Firefly custom models analyze your assets to preserve character designs and emulate illustration and photography styles. Firefly custom models analyze your assets to preserve character designs and ...

OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

There is a Google patent named AI-generated content page tailored to a specific user. It describes the use of AI to create custom landing pages and when a user performs a search, Google Search sends ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...